61
TITLE: Different Clinical Characteristics of Paroxysmal Nocturnal Hemoglobinuria in Pediatric and Adult Patients
AUTHORS: Alvaro Urbano Ispizua; Petra Muus; Hubert Schrezenmeier; Antonio Medina Almeida; Amanda Vilson; Russell E Ware;
PUBLISHED: 2015, SOURCE: 57th Annual Meeting of the American-Society-of-Hematology in BLOOD, VOLUME: 126, ISSUE: 23
INDEXED IN: WOS
62
TITLE: THE EFFECT OF LENALIDOMIDE ON HEALTH-RELATED QUALITY OF LIFE (HRQOL) IN PATIENTS WITH MDS: RESULTS FROM THE MDS-005 TRIAL  Full Text
AUTHORS: Santini, V; Almeida, A; Giagounidis, A; Bartiromo, C; Hoenekopp, A; Guo, S; Beach, CL; Altincatal, A; Wu, C; Skikne, B; Zhong, J; Hu, XH; Fenaux, P;
PUBLISHED: 2015, SOURCE: 13th International Symposium on Myelodysplastic Syndromes (MDS) in LEUKEMIA RESEARCH, VOLUME: 39
INDEXED IN: WOS
63
TITLE: EFFICACY OF AZACITIDINE IN MDS, CMML AND AML WITH PROLIFERATIVE FEATURES  Full Text
AUTHORS: Almeida, AM; Pierdomenico, F;
PUBLISHED: 2015, SOURCE: 13th International Symposium on Myelodysplastic Syndromes (MDS) in LEUKEMIA RESEARCH, VOLUME: 39
INDEXED IN: WOS
64
TITLE: Optimizing treatments in rare diseases: Will our evidence come from registry data?  Full Text
AUTHORS: Antonio M Almeida;
PUBLISHED: 2014, SOURCE: LEUKEMIA RESEARCH, VOLUME: 38, ISSUE: 4
INDEXED IN: Scopus WOS CrossRef
IN MY: ORCID
65
TITLE: Survey of professional competence in hematology in Europe  Full Text
AUTHORS: Eva Hellstrom Lindberg; Antonio Almeida; Fredrik Enoksson; Thom Duyvene de Wit; Janet Strivens; Ambjorn Naeve; Cheng Hock Toh;
PUBLISHED: 2014, SOURCE: HAEMATOLOGICA, VOLUME: 99, ISSUE: 3
INDEXED IN: Scopus WOS CrossRef
66
TITLE: Cell-type-specific transcriptional regulation of PIGM underpins the divergent hematologic phenotype in inherited GPl deficiency
AUTHORS: Joana R Costa; Valentina S Caputo; Kalliopi Makarona; Mark M Layton; Irene A G Roberts; Antonio M Almeida; Anastasios Karadimitris;
PUBLISHED: 2014, SOURCE: BLOOD, VOLUME: 124, ISSUE: 20
INDEXED IN: Scopus WOS CrossRef
IN MY: ORCID
67
TITLE: Efficacy and Safety of Lenalidomide (LEN) Versus Placebo (PBO) in RBC-Transfusion Dependent (TD) Patients (Pts) with IPSS Low/Intermediate (Int-1)-Risk Myelodysplastic Syndromes (MDS) without Del(5q) and Unresponsive or Refractory to Erythropoiesis-Stimulating Agents (ESAs): Results from a Randomized Phase 3 Study (CC-5013-MDS-005)
AUTHORS: Valeria Santini; Antonio Almeida; Aristoteles Giagounidis; Stephanie Groepper; Anna Jonasova; Norbert Vey; Ghulam J Mufti; Rena Buckstein; Moshe Mittelman; Uwe Platzbecker; Ofer Shpilberg; Ron Ram; Consuelo del Canizo; Norbert Gattermann; Keiya Ozawa; Jim Zhong; Francis Seguy; Albert Hoenekopp; Beach, CL; Pierre Fenaux;
PUBLISHED: 2014, SOURCE: 56th Annual Meeting of the American-Society-of-Hematology in BLOOD, VOLUME: 124, ISSUE: 21
INDEXED IN: WOS
69
TITLE: Treatment of acute erythroleukemia with Azacitidine: A case series
AUTHORS: Pierdomenico, F; Almeida, A;
PUBLISHED: 2013, SOURCE: Leukemia Research Reports, VOLUME: 2, ISSUE: 2
INDEXED IN: Scopus CrossRef
IN MY: ORCID
70
TITLE: Clinical management of gastrointestinal disturbances in patients with myelodysplastic syndromes receiving iron chelation treatment with deferasirox  Full Text
AUTHORS: Nolte, F; Angelucci, E; Beris, P; Macwhannell, A; Selleslag, D; Schumann, C; Xicoy, B; Almeida, A; Guerci Bresler, A; Sliwa, T; Muus, P; Porter, J; Hofmann, WK;
PUBLISHED: 2011, SOURCE: Leukemia Research, VOLUME: 35, ISSUE: 9
INDEXED IN: Scopus CrossRef
IN MY: ORCID
Page 7 of 9. Total results: 85.